Description
The present invention is directed to the novel compounds, formula (I) and methods for flavivirus infection, such as the serotype 2 dengue viral infection in human body. The invention is based upon the in vitro implying the monolayer of HepG2 cells that was derived from human hepatomas which closely resembles the true target tissue of liver that was involved in the pathogenesis of dengue fever.
Contact Person/Inventor
| Name | Contact Phone | |
|---|---|---|
| Um Centre Of Innovation And Enterprise (Umcie) | umcie@um.edu.my | 013-2250151 / 03-79677351 |
Intellectual Property
| № | Type of IP | Registration ID |
|---|---|---|
| 1 | Patent Filed | PI 2015704523 |
Award
| Award Title | Award Achievement | Award Year Received |
|---|---|---|
| 0 | 0 | 0 |
-
Organisation Name
- UNIVERSITY OF MALAYAUNIVERSITI MALAYA50603KUALA LUMPUR
Comment